Log In
person
Apellis Pharmaceuticals Inc
APLS
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma for Immunotherapy |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
366.28M | 92.36% |
| Pharma for Immunotherapy |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
30.31M | 7.64% |
| keyboard_arrow_down |
Pharma for Immunotherapy
Branded Pharmaceuticals (outsourced)
|
366.28M | 92.36% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Pharma for Immunotherapy
Pharmaceutical Patent Licensing
|
30.31M | 7.64% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||